The website "Cancer Immunotherapy (C-IMT)" represents an information and education platform to achieve three complementary targets:

1. The organization of annual meetings on cancer immunotherapy. These meetings should present an update on the fundamentals and the clinical aspects of cancer immunotherapy.
   
   
2. The creation of an Internet data base "clinical trials", accessible to physicians and interested public. The Web portal is designed to provide both groups of interest with:
   
   
   • the possibility to easily search for current trials and
   • the ability to establish contact with the respective investigators of clinical trials.
     
     
3. The set-up of a communication platform for scientists and clinicians devoted to Cancer Immunotherapy.

News 

An initiative of members from the "Regulatory Research" working group as well as of CIMT members has been started to prevent further regulatory hurdles for nucleotide based tumor vaccines. The text, which is forwarded to the European Medical Agency (EMEA), can be downloaded as PDF.  

See also EU webpage: http://ec.europa.eu/